HR 4724
115th Congress
House
Health
Congressional oversight
Drug therapy
Government studies and investigations
Health care costs and insurance
Health care coverage and access
Home and outpatient care
Medicare
Neurological disorders
Medicare IVIG Access Enhancement Act
Introduced: December 21, 2017
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 22, 2017
Referred to the Subcommittee on Health.
Dec 21, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 21, 2017
Introduced in House
Plain-English summary
Medicare IVIG Access Enhancement Act
This bill requires the Centers for Medicare & Medicaid Services to establish a three-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3